Joel A Sincavage

Array ( [id] => 11773745 [patent_doc_number] => 09382589 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-05 [patent_title] => 'Individualized cancer therapy' [patent_app_type] => utility [patent_app_number] => 14/071490 [patent_app_country] => US [patent_app_date] => 2013-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 61 [patent_no_of_words] => 17452 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14071490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10422872 [patent_doc_number] => 20150307883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-29 [patent_title] => 'APTAMERS, MULTIMERIC APTAMERS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/439248 [patent_app_country] => US [patent_app_date] => 2013-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15894 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14439248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10155985 [patent_doc_number] => 09187747 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-17 [patent_title] => 'RNAi modulation of ApoB and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/058679 [patent_app_country] => US [patent_app_date] => 2013-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 41240 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14058679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15574473 [patent_doc_number] => 10577604 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-03 [patent_title] => Methods for monitoring C9ORF72 expression [patent_app_type] => utility [patent_app_number] => 14/436039 [patent_app_country] => US [patent_app_date] => 2013-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 26308 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14978293 [patent_doc_number] => 10443052 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-15 [patent_title] => Compositions for modulating C9ORF72 expression [patent_app_type] => utility [patent_app_number] => 14/436024 [patent_app_country] => US [patent_app_date] => 2013-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23457 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10399716 [patent_doc_number] => 20150284725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-08 [patent_title] => 'METHODS OF TREATING KENNEDY\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 14/434693 [patent_app_country] => US [patent_app_date] => 2013-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41114 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14434693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9409011 [patent_doc_number] => 20140100263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-10 [patent_title] => 'METHODS FOR TREATMENT OF ALPORT SYNDROME' [patent_app_type] => utility [patent_app_number] => 14/048827 [patent_app_country] => US [patent_app_date] => 2013-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18474 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14048827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10102703 [patent_doc_number] => 09138474 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-22 [patent_title] => 'Composition comprising expression or activity inhibitors of Ninjurin1 for the prevention and treatment of inflammatory disease' [patent_app_type] => utility [patent_app_number] => 14/046436 [patent_app_country] => US [patent_app_date] => 2013-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 28 [patent_no_of_words] => 10699 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14046436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10505260 [patent_doc_number] => 09233119 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-12 [patent_title] => 'Use of HGMA-targeted phosphorothioate DNA aptamers to suppress carcinogenic activity and increase sensitivity to chemotherapy agents in human cancer cells' [patent_app_type] => utility [patent_app_number] => 14/037554 [patent_app_country] => US [patent_app_date] => 2013-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 30 [patent_no_of_words] => 11801 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14037554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9408877 [patent_doc_number] => 20140100129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-10 [patent_title] => 'METHOD OF THERAPY AND DIAGNOSIS OF ATHEROSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 14/035249 [patent_app_country] => US [patent_app_date] => 2013-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 7788 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14035249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9223638 [patent_doc_number] => 20140018412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'Methods for Diagnosing Lung Cancer using MicroRNAs' [patent_app_type] => utility [patent_app_number] => 14/032855 [patent_app_country] => US [patent_app_date] => 2013-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 31660 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14032855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10056221 [patent_doc_number] => 09095561 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'Methods for affecting homology-directed DNA double stranded break repair' [patent_app_type] => utility [patent_app_number] => 14/028702 [patent_app_country] => US [patent_app_date] => 2013-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 3674 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14028702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11922920 [patent_doc_number] => 09790492 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-17 [patent_title] => 'Agent for treating cancer' [patent_app_type] => utility [patent_app_number] => 14/421337 [patent_app_country] => US [patent_app_date] => 2013-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 19777 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14421337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9192122 [patent_doc_number] => 20130331437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'METHODS FOR MODULATING THE EXPRESSION AND AGGREGATION OF CAG-EXPANDED GENE PRODUCT IN CELLS AND METHODS FOR IDENTIFYING AGENTS USEFUL FOR DOING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/936696 [patent_app_country] => US [patent_app_date] => 2013-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6122 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13936696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9192120 [patent_doc_number] => 20130331435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'ANTISENSE MODULATION OF KINESIN-LIKE 1 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/905306 [patent_app_country] => US [patent_app_date] => 2013-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26779 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13905306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8990477 [patent_doc_number] => 20130217758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'MULTIANTIVIRUS COMPOUND, COMPOSITION AND METHOD FOR TREATMENT OF VIRUS DISEASES' [patent_app_type] => utility [patent_app_number] => 13/846402 [patent_app_country] => US [patent_app_date] => 2013-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20924 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13846402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11908472 [patent_doc_number] => 09777275 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-03 [patent_title] => 'Oligonucleotide compositions with enhanced efficiency' [patent_app_type] => utility [patent_app_number] => 13/800845 [patent_app_country] => US [patent_app_date] => 2013-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23467 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13800845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10560889 [patent_doc_number] => 09284551 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-15 [patent_title] => 'RNAi sequence-independent modification formats, and stabilized forms thereof' [patent_app_type] => utility [patent_app_number] => 13/782441 [patent_app_country] => US [patent_app_date] => 2013-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 77 [patent_no_of_words] => 35475 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13782441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10019619 [patent_doc_number] => 09062090 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'Piggy-back delivery of nucleic acids into organisms' [patent_app_type] => utility [patent_app_number] => 13/782645 [patent_app_country] => US [patent_app_date] => 2013-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6209 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13782645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8916888 [patent_doc_number] => 20130178513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-11 [patent_title] => 'MODULATION OF EIF4E EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/780955 [patent_app_country] => US [patent_app_date] => 2013-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52795 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13780955 [rel_patent_id] =>[rel_patent_doc_number] =>)